American Healthcare REIT

AHR on NYSE. American Healthcare REIT rents healthcare buildings to senior housing and medical operators. Market value $11.0bn.

Watch this stockFree. We tell you when something changes.

Price checks use the past 12 months to June 2026. Some use the latest annual report instead, as marked. Quality checks use five annual reports, the latest for the year to December 2025.

We can't read total debt from the filing, so debt is left out.

Cash flow or capital spending isn't reported, so free cash flow is unknown.

Should I look at this?

Not a fit for our list right now

See Real estate stocks that passed both tests

This is not advice. Check the numbers below.

Compare with another stock

Cash yield
annual report to December 2025
n/a

We could not compute this from the filings.

Price to profit
past 12 months to June 2026
n/a

The filings do not give us enough to work this out.

Return on capital
five annual reports to December 2025
n/a

The filings do not give us enough to work this out.

Quality score: not known. Price score: not known. Our list needs 70 on quality and 60 on price.

$50.47 a share, 26% above its 1-year low

Over the past year the price has ranged from $40.00 to $58.70.

Dividend: 1.5% a year

Paid every year for at least 5 years

Payouts have jumped around in recent years, so this may not repeat.

Prices from Monday’s close (5 October).

Five years of cash, in billions

n/a
n/a
n/a
n/a
n/a
20212022202320242025
Revenue
$1.1bn$1.4bn$1.9bn$2.1bn$2.3bn
Operating margin
19.0%21.4%16.4%17.6%18.4%
Debt to equity
n/an/an/an/an/a
Shares outstanding
0.05bn0.07bn0.15bn0.18bn0.22bn

Health checks

  • Free cash flow positiveNot enough data
  • Accounting looks honest (Beneish)Not enough data
  • Financial strength (Piotroski)Not enough data
  • Profit backed by cash (accruals)Yes
  • DebtUnknown
  • Revenue growth, five yearsStrong, 16.2% a year
  • Buying back its own sharesNo, 335% more shares since 2021

The quarter to June 2026

How the business did, compared with the same quarter a year earlier.

  • Sales: $674 million last quarter, up 24% on a year ago.
  • Profit: $31 million, up 209% on a year ago.
  • It keeps 19 cents of each $1 of sales as operating profit, up from 18 cents a year earlier.
  • 20% more shares than a year ago. Each share owns a bit less of the company.
  • Sales grew on a year ago in each of the last 4 quarters.
Sales by quarter
Sales by quarter
Quarter toAmount
September 2024$524m
December 2024$543m
March 2025$541m
June 2025$543m
September 2025$573m
December 2025$604m
March 2026$651m
June 2026$674m
Profit by quarter
Profit by quarter
Quarter toAmount
September 2024-$4m
December 2024-$32m
March 2025-$7m
June 2025$10m
September 2025$56m
December 2025$11m
March 2026$24m
June 2026$31m

From the company's quarterly reports to the SEC.

Dates

Next results (estimated)
n/a
Last annual report (10-K)
27 February 2026
Next quarterly (estimated, 10-Q)
6 November 2026

Who owns it

3 long-term investors we follow own it, unchanged from 3 last quarter. 570 funds in all.

Jun '25
Dec '25
Jun '26
Largest holders overall

From 13F filings for the quarter ended 30 June 2026.

Big holders and activists

5 investors own more than 5%.

From Schedule 13D and 13G filings: anyone owning more than 5% must file one.

What insiders did

No insider bought shares on the open market in the last 12 months. 3 sold $5m, $304,520 of it under preset trading plans.

  • Foster Mark E.
    EVP, GC & Secretary
    Sold
    Date
    25 September 2026
    Shares
    1,500
    Price
    $52.06
    Value
    $78,090
  • Foster Mark E.
    EVP, GC & Secretary
    Sold
    under a preset trading plan
    Date
    1 September 2026
    Shares
    2,000
    Price
    $55.39
    Value
    $110,780
  • PEAY BRIAN
    Chief Financial Officer
    Sold
    Date
    26 June 2026
    Shares
    25,000
    Price
    $50.70
    Value
    $1m
  • Foster Mark E.
    EVP, GC & Secretary
    Sold
    Date
    24 June 2026
    Shares
    2,500
    Price
    $48.58
    Value
    $121,450
  • Foster Mark E.
    EVP, GC & Secretary
    Sold
    under a preset trading plan
    Date
    1 June 2026
    Shares
    2,000
    Price
    $48.32
    Value
    $96,640
  • Foster Mark E.
    EVP, GC & Secretary
    Sold
    under a preset trading plan
    Date
    25 March 2026
    Shares
    2,000
    Price
    $48.55
    Value
    $97,100
  • Hanson Jeffrey T
    Director
    Sold
    Date
    23 December 2025
    Shares
    19,208
    Price
    $48.40
    Value
    $929,667
  • Hanson Jeffrey T
    Director
    Sold
    Date
    22 December 2025
    Shares
    35,570
    Price
    $48.38
    Value
    $2m
  • Foster Mark E.
    EVP, GC & Secretary
    Sold
    Date
    11 November 2025
    Shares
    1,500
    Price
    $49.35
    Value
    $74,025
  • Hanson Jeffrey T
    Director
    Sold
    Date
    10 November 2025
    Shares
    20,010
    Price
    $49.68
    Value
    $994,097

From Form 4 filings: insiders must report trades in their own company's shares within two days.

Warning signs in its filings

Problems the company itself reported to the SEC, in its own words.

None of the warning signs we check for were found.

We look for five warning signs: doubt it can keep going, weak checks on its own accounts, a notice that its past accounts can't be relied on, a change of auditor, and one customer bringing in a big share of sales. We don't check lawsuits, investigations or debt yet.

We checked the auditor's report, internal controls, restatement notices, auditor changes and big customers in the 10-K filed 27 Feb 2026, plus the 10-Q filed 7 Aug 2026 and 16 later 8-Ks.

A 10-K is the yearly report every US company files with the SEC. An 8-K is a short notice of a big event.

What could go wrong

Cheap for a reason is the question the numbers cannot answer.

Whether the price already reflects the risks is what the deep dive is for.

The deep dive

Everything above is arithmetic on public filings. The deep dive reads the last ten years of annual reports, the proxy statements, and the earnings calls, then argues the case the way Buffett, Klarman, and Hohn would, and checks every claim against the source.

  • What the business is worth, as a range, and the margin of safety at today’s price
  • Prices to start buying, buy, and buy hard
  • The three things that would make this a mistake
  • Every number footnoted to the filing it came from
Create a free account to run it

Your first deep dive is free.

What a finished deep dive looks like

Not advice. Numbers on this page come from SEC filings and are updated each night; prices are updated again after the US market closes. The five-year figures are rounded.